Last SFr.270.10 CHF
Change Today -3.20 / -1.17%
Volume 1.4M
As of 11:43 AM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andres F. Leuenberger

Former Vice Chairman, Roche Holding AG
AgeTotal Calculated CompensationThis person is connected to 18 board members in 1 different organizations across 5 different industries.

See Board Relationships
76--

Background*

Mr. Andres F. Leuenberger served as President and Chief Executive Officer of Nippon Roche K.K., Tokyo from 1973 to 1980. Mr. Leuenberger was an Area Manager of F. Hoffmann-La Roche & Co. Ltd., since joining in 1968 and Manager of Pharma Marketing of Nippon Roche K.K., Tokyo in 1970. He joined the Swiss Life/Rentenanstalt Board of Directors in June 1998 and served as its Chairman since 2000. Mr. Leuenberger served as the Chairman of Swiss Life Holding (formerly, Schweizerische ...

Read Full Background

Corporate Headquarters*

Grenzacherstrasse 124
Basel, Basel-Stadt 4070

Switzerland

Phone: 41 61 688 11 11
Fax: 41 61 691 93 91

Board Members Memberships*

Former Chairman
Director
1983-N/A
Former Vice Chairman
1994-2008
Former Vice Chairman, Chairman of Compensation Committee, Member of Audit Committee and Member of Nomination & Governance Committee
1998-2004
Former Director

Education*

Doctorate
University of Neuchâtel
PhD
University of Neuchâtel
Unknown/Other Education
Universität Basel
Master's Degree
Universität St. Gallen
MBA
Universität St. Gallen

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROG:VX SFr.270.10 CHF -3.20

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Jeffrey R. Immelt Executive Chairman and Chief Executive Officer
General Electric Company
$8.5M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.